BAP1 anticorps (AA 460-729)

N° du produit ABIN7174361

Cet anticorps Lapin Polyclonal détecte spécifiquement BAP1 dans WB et ELISA. Il présente une réactivité envers Humain.

Aperçu rapide pour BAP1 anticorps (AA 460-729) (ABIN7174361)

Antigène: BAP1 (BRCA1 Associated Protein-1 (Ubiquitin Carboxy-terminal Hydrolase) (BAP1))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp BAP1 est non-conjugé

Application: Western Blotting (WB), ELISA

Détail du produit anti-BAP1 anticorps

Épitope: AA 460-729

Réactivité croisée: Humain

Purification: Antigen Affinity Purified

Immunogène: Recombinant Human Ubiquitin carboxyl-terminal hydrolase BAP1 protein (460-729AA)

Isotype: IgG

Information d'application

Indications d'application: Recommended dilution: WB:1:200-1:1000,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur BAP1

Antigène: BAP1 (BRCA1 Associated Protein-1 (Ubiquitin Carboxy-terminal Hydrolase) (BAP1))

Autre désignation: BAP1

Sujet:

Background: Deubiquitinating enzyme that plays a key role in chromatin by mediating deubiquitination of histone H2A and HCFC1. Catalytic component of the PR-DUB complex, a complex that specifically mediates deubiquitination of histone H2A monoubiquitinated at \\\'Lys-119\\\' (H2AK119ub1). Does not deubiquitinate monoubiquitinated histone H2B. Acts as a regulator of cell growth by mediating deubiquitination of HCFC1 N-terminal and C-terminal chains, with some specificity toward \\\'Lys-48\\\'-linked polyubiquitin chains compared to \\\'Lys-63\\\'-linked polyubiquitin chains. Deubiquitination of HCFC1 does not lead to increase stability of HCFC1. Interferes with the BRCA1 and BARD1 heterodimer activity by inhibiting their ability to mediate ubiquitination and autoubiquitination. It however does not mediate deubiquitination of BRCA1 and BARD1. Able to mediate autodeubiquitination via intramolecular interactions to couteract monoubiquitination at the nuclear localization signal (NLS), thereby protecting it from cytoplasmic sequestration (PubMed:24703950). Acts as a tumor suppressor.

Aliases: BAP 1 antibody, Bap1 antibody, BAP1_HUMAN antibody, BRCA 1 associated protein 1 antibody, BRCA1 associated protein 1 antibody, BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) antibody, BRCA1-associated protein 1 antibody, Cerebral protein 13 antibody, Cerebral protein 6 antibody, DKFZp686N04275 antibody, FLJ35406 antibody, FLJ37180 antibody, HUCEP 13 antibody, Hucep 6 antibody, HUCEP13 antibody, Hucep6 antibody, KIAA0272 antibody, TPDS antibody, Ubiquitin carboxy terminal hydrolase antibody, Ubiquitin carboxyl terminal hydrolase BAP 1 antibody, Ubiquitin carboxyl terminal hydrolase BAP1 antibody, Ubiquitin carboxyl-terminal hydrolase BAP1 antibody, UCHL2 antibody

UniProt: Q92560